Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda trial registry — 741 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Takeda clinical trials

Registry index of 741 ClinicalTrials.gov studies linked to Takeda programs — each row shows trial ID, program name, phase, status, and indication.

Takeda trial registry — 741 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Takeda.

  1. TAK-861-3002 — Phase 3

    Clinical update

  2. TAK-079-3001 — Phase 3

    Clinical update

  3. MLN0002-3029 — Phase 3

    Clinical update

  4. MLN0002-3024 — Phase 3

    Clinical update

  5. KER-050-D301 — Phase 3

    Clinical update

  6. DEN-303 — Phase 3

    Clinical update

  7. SPD476-302 — Phase 3

    Clinical update

  8. 061002 — Phase 3

    Clinical update

Trial registry

741 studies
  9. 2023-506415-18-00

    ADCETRIS 50 mg powder for concentrate for solution for infusion

    Phase 2 active small_molecule

    Hodgkin lymphoma (HL) - Hodgkin lymphoma (HL), a neoplasm of lymphoid tissue which is histopathologically defined by the presence of malignant Hodgkin Reed-Sternberg (HRS) cells in a background of inflammatory cells. The proposed pediatric study has been designed to evaluate brentuximab vedotin as a component of a multiagent frontline chemotherapy regimen in patients with advanced stage, newly diagnosed HL, here defined as Stage III and Stage IV and a ≥50 Lansky Play-Performance or Karnofsky Performance Status.

    CTIS ↗
  17. 2023-508988-73-00

    TAK-620-2004

    Phase 3 active small_molecule

    Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

    CTIS ↗
  31. 2024-518420-80-00

    TAK-339-3001

    Phase 3 active small_molecule

    Primary infection prophylaxis for secondary immunodeficiency (SID) in patients with multiple myeloma (MM) receiving B cell maturation antigen (BCMA)-directed bispecific (BsAb) therapy

    CTIS ↗
  402. NCT01732692

    MOVIPREP

    Phase 3 completed small_molecule

    Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.

    CT.gov ↗

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.